Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | HPGD | P15428 | 4/20 | 0.61 |
| ▸ | F2 | P00734 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 7/20 | 0.60 |
| ▸ | C1R | P00736 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | F7 | P08709 | 1/20 | 0.56 |
| ▸ | F3 | P13726 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5385451 | 0.88 | HPN (0.52) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL10741223 | 0.86 | HPN (0.61) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL272872 | 0.85 | ELANE (0.83) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL14273715 | 0.85 | KDM4E (0.58) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL11817024 | 0.85 | ELANE (0.71) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL5385483 | 0.84 | F7 (0.49) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL3452610 | 0.83 | ELANE (0.60) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL8493130 | 0.83 | ELANE (0.67) | ELANEKMT2AALDH1A1HPGDF2 | |
| SCHEMBL5371857 | 0.82 | MAPT (0.64) | KMT2AALDH1A1HPGDF2C1R | |
| SCHEMBL5921381 | 0.82 | ELANE (0.71) | ELANEKMT2AALDH1A1HPGDF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3970652-A | Selectively herbicidal 2-substituted-4H-3,1-benzoxazin-4-ones | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1976-07-20 | — | — | US | claimed |
| EP-3628374-B1 | BCL-3 INHIBITORS | UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) | 2023-08-30 | — | — | EP | disclosed |
| EP-3628374-B1 | BCL-3 INHIBITORS | UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) | 2023-08-30 | — | — | EP | disclosed |
| EP-3628374-A2 | BCL-3 INHIBITORS | University College Cardiff Consultants Limited (GB) | 2020-04-01 | — | — | EP | disclosed |
| EP-3628374-A2 | BCL-3 INHIBITORS | University College Cardiff Consultants Limited (GB) | 2020-04-01 | — | — | EP | disclosed |
| US-20190248756-A1 | BCL-3 INHIBITORS | UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) | 2019-08-15 | — | — | US | disclosed |
| US-20190248756-A1 | BCL-3 INHIBITORS | UNIV COLLEGE CARDIFF CONSULTANTS LTD (GB) | 2019-08-15 | — | — | US | disclosed |
| US-10273218-B2 | BCL-3 inhibitors | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2019-04-30 | — | — | US | disclosed |
| US-10273218-B2 | BCL-3 inhibitors | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2019-04-30 | — | — | US | disclosed |
| US-20170267653-A1 | BCL-3 INHIBITORS | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2017-09-21 | — | — | US | disclosed |
| EP-0067382-A2 | N-cyclohexyl-chloroacetamides, their preparation and their use in combating undesired plant growth | BASF Aktiengesellschaft (DE) | 1982-12-22 | — | — | EP | disclosed |
| US-4363651-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1982-12-14 | — | — | US | disclosed |
| EP-0053698-A1 | 5-Amino-1-phenylpyrazole-4-carboxylic acids, process for their preparation, herbicides containing them and their use as herbicides | BASF Aktiengesellschaft (DE) | 1982-06-16 | — | — | EP | disclosed |
| EP-0053678-A1 | 5-Amino-1-phenyl-4-cyano pyrazoles, herbicides containing them, process for their preparation and their use as herbicides | BASF Aktiengesellschaft (DE) | 1982-06-16 | — | — | EP | disclosed |
| EP-0049398-A1 | 4H-3,1-Benzoxazin derivatives, process for their preparation and their use as herbicides | BASF Aktiengesellschaft (DE) | 1982-04-14 | — | — | EP | disclosed |
| US-4321371-A | Substituted N-benzoylanthranilic acid derivatives and their anhydro compounds | BASF AKTIENGESELLSCHAFT (DE) | 1982-03-23 | — | — | US | disclosed |
| EP-0032242-A1 | 4H-3,1-benzoxazine derivatives, process for their preparation and their use in inhibiting the growth of unwanted plants | BASF Aktiengesellschaft (DE) | 1981-07-22 | — | — | EP | disclosed |
| EP-0024669-A1 | Substituted N-benzoylanthranilic acid derivatives and their anhydro derivatives, process for their preparation, their use as herbicides and compositions therefor | BASF Aktiengesellschaft (DE) | 1981-03-11 | — | — | EP | disclosed |
| US-3970652-A | Selectively herbicidal 2-substituted-4H-3,1-benzoxazin-4-ones | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1976-07-20 | — | — | US | disclosed |
| US-3970652-A | Selectively herbicidal 2-substituted-4H-3,1-benzoxazin-4-ones | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248756-A1 | BCL-3 INHIBITORS | BCL3, BCL2, BCL2L13 | ELANE 4060/4885KMT2A 3099/4885ALDH1A1 2635/4885 |
| US-10273218-B2 | BCL-3 inhibitors | BCL3, BCL2, BCL2L13 | ELANE 3860/4885KMT2A 2931/4885ALDH1A1 2830/4885 |
| US-20170267653-A1 | BCL-3 INHIBITORS | BCL3, BCL2, BCL2L13 | ELANE 3860/4885KMT2A 2931/4885ALDH1A1 2830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.